All patients taking methotrexate for treatment of psoriasis over the past 5yr have been reviewed. Thirty-eight patients have had pretreatment liver biopsies and at least 1 repeat liver biopsy. Of the 38, nine (24%) have developed significant liver fibrosis or cirrhosis, and have stopped treatment.The high incidence of fibrosis is attributed to synergism between methotrexate and other hepatotoxic factors, particularly alcohol, the use of a baseline biopsy to identify subsequent changes, and the early detection of fibrosis by sensitive histological techniques
Background & Aims: The risk of significant liver fibrosis from prolonged methotrexate (MTX) exposure...
Background & Aims: The risk of significant liver fibrosis from prolonged methotrexate (MTX) exposure...
Contains fulltext : 50706.pdf (publisher's version ) (Closed access)BACKGROUND: Me...
All patients taking methotrexate for treatment of psoriasis over the past 5yr have been reviewed. Th...
Seventy patients with psoriasis severe enough to require methotrexate therapy were evaluated to asse...
Seventy patients with psoriasis severe enough to require methotrexate therapy were evaluated to asse...
Methotrexate is an anchor-drug for the treatment of inflammatory arthritides affecting peripheral jo...
BACKGROUND: Methotrexate-induced liver damage in psoriasis has led to dermatologic guidelines that s...
55 year old male patient diagnosed to have psoriasis 2.5 years ago and was started on methotrexate 5...
SYNOPSIS A case is described in which marked hepatic fibrosis probably resulted from the prolonged t...
BACKGROUND: Methotrexate (MTX) use is associated with hepatic fibrosis in psoriasis patients. To mon...
Aim. Long-term methotrexate (MTX) treatment can cause hepatic damage that may lead to the developmen...
BACKGROUND AND DESIGN: Methotrexate (MTX) hepatotoxicity in psoriatic patients is well recognized, b...
Background & AimsThe risk of significant liver fibrosis from prolonged methotrexate (MTX) exposure h...
Background & Aims: The risk of significant liver fibrosis from prolonged methotrexate (MTX) exposure...
Background & Aims: The risk of significant liver fibrosis from prolonged methotrexate (MTX) exposure...
Background & Aims: The risk of significant liver fibrosis from prolonged methotrexate (MTX) exposure...
Contains fulltext : 50706.pdf (publisher's version ) (Closed access)BACKGROUND: Me...
All patients taking methotrexate for treatment of psoriasis over the past 5yr have been reviewed. Th...
Seventy patients with psoriasis severe enough to require methotrexate therapy were evaluated to asse...
Seventy patients with psoriasis severe enough to require methotrexate therapy were evaluated to asse...
Methotrexate is an anchor-drug for the treatment of inflammatory arthritides affecting peripheral jo...
BACKGROUND: Methotrexate-induced liver damage in psoriasis has led to dermatologic guidelines that s...
55 year old male patient diagnosed to have psoriasis 2.5 years ago and was started on methotrexate 5...
SYNOPSIS A case is described in which marked hepatic fibrosis probably resulted from the prolonged t...
BACKGROUND: Methotrexate (MTX) use is associated with hepatic fibrosis in psoriasis patients. To mon...
Aim. Long-term methotrexate (MTX) treatment can cause hepatic damage that may lead to the developmen...
BACKGROUND AND DESIGN: Methotrexate (MTX) hepatotoxicity in psoriatic patients is well recognized, b...
Background & AimsThe risk of significant liver fibrosis from prolonged methotrexate (MTX) exposure h...
Background & Aims: The risk of significant liver fibrosis from prolonged methotrexate (MTX) exposure...
Background & Aims: The risk of significant liver fibrosis from prolonged methotrexate (MTX) exposure...
Background & Aims: The risk of significant liver fibrosis from prolonged methotrexate (MTX) exposure...
Contains fulltext : 50706.pdf (publisher's version ) (Closed access)BACKGROUND: Me...